Mechanical Circulatory Support for Advanced Heart Failure: Are We about to Witness a New “Gold Standard”?
Author:
Publisher
MDPI AG
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Link
http://www.mdpi.com/2308-3425/3/4/35/pdf
Reference131 articles.
1. The REMATCH trial: rationale, design, and end points
2. Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart Failure
3. Left ventricular assist devices as destination therapy: A new look at survival
4. Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
5. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development and validation of a mathematical model for evaluating shear-induced damage of von Willebrand factor;Computers in Biology and Medicine;2023-09
2. A Bio-Mechanical System of Systems for Heart Failure Patients;2022 IEEE International Symposium on Systems Engineering (ISSE);2022-10-24
3. (Physiology of Continuous-flow Left Ventricular Assist Device Therapy. Translation of the document prepared by the Czech Society of Cardiology);Cor et Vasa;2022-04-26
4. Pulsatile versus nonpulsatile blood flow during cardiopulmonary bypass;International Anesthesiology Clinics;2022
5. Physiology of Continuous‐Flow Left Ventricular Assist Device Therapy;Comprehensive Physiology;2021-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3